Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2

References

[1] Carlson, C.R., Asfaha, J.B., Ghent, C.M., Howard, C.J., Hartooni, N., and Morgan, D.O.(2020). Phosphorylation modulates liquidliquid phase separation of the SARS-CoV-2 N protein. bioRxiv.

[2] Chang CK, Hou MH, Chang CF, Hsiao CD, Huang TH (2014) The SARS coronavirus nucleocapsid protein–forms and functions. Antiviral Res 103:39–50

[3] Cong, Y.Y., Ulasli, M., Schepers, H., Mauthe, M., V’kovski, P., Kriegenburg, F., Thiel, V., de Haan, C.A.M., and Reggiori, F. (2020). Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. J Virol 94.

[4] Ge YY, Tian TZ, Huang SL, Wan FP, Li JX, Li SY, Yang H, Hong LX, Wu N, Yuan EM (2020) A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. bioRxiv.

[5] Hurst KR, Koetzner CA, Masters PS (2013) Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex. J Virol 87:9159–9172

[6] Iserman C, Roden C, Boerneke M, Sealfon R, McLaughlin G, Jungreis I, Park C, Boppana A, Fritch E, Hou YJ (2020) Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. bioRxiv.

[7] Klein IA, Boija A, Afeyan LK, Hawken SW, Fan M, Dall’Agnese A, Oksuz O, Henninger JE, Shrinivas K, Sabari BR (2020) Partitioning of cancer therapeutics in nuclear condensates. Science 368:1386–1392

[8] Lin SY, Liu CL, Chang YM, Zhao J, Perlman S, Hou MH (2014) Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target. J Med Chem 57:2247–2257

[9] Malik YA (2020) Properties of Coronavirus and SARS-CoV-2. Malays J Pathol 42:3–11

[10] Nelson GW, Stohlman SA,Tahara SM (2000) High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA. J General Virol 81:181–188

[11] Perdikari, T.M., Murthy, A.C., Ryan, V.H., Watters, S., Naik, M.T., and Fawzi, N.L. (2020). SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. bioRxiv.

[12] Savastano, A.,Opakua, A.L., Rankovic, M., Zweckstetterc, M. (2020). Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. bioRxiv.

[13] Stohlman SA, Baric RS, Nelson GN, Soe LH, Welter LM, Deans RJ (1988) Specific interaction between coronavirus leader RNA and nucleocapsid protein. J Virol 62:4288–4295

[14] Surjit M, Lal SK (2008) The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect Genet Evol 8:397–405

RIGHTS & PERMISSIONS

The Author(s)